382 related articles for article (PubMed ID: 12020864)
21. Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum.
Gray AC; White PJ; Coupar IM
Br J Pharmacol; 2005 Mar; 144(5):687-94. PubMed ID: 15678085
[TBL] [Abstract][Full Text] [Related]
22. Neuropeptide Y blocks light-induced phase advances but not delays of the circadian activity rhythm in hamsters.
Weber ET; Rea MA
Neurosci Lett; 1997 Aug; 231(3):159-62. PubMed ID: 9300646
[TBL] [Abstract][Full Text] [Related]
23. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
[TBL] [Abstract][Full Text] [Related]
24. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
[TBL] [Abstract][Full Text] [Related]
25. The possible involvement of endogenous ligands for mu-, delta- and kappa-opioid receptors in modulating morphine-induced CPP expression in rats.
Liang J; Li Y; Ping X; Yu P; Zuo Y; Wu L; Han JS; Cui C
Peptides; 2006 Dec; 27(12):3307-14. PubMed ID: 17097192
[TBL] [Abstract][Full Text] [Related]
26. Short-term exposure to constant light promotes strong circadian phase-resetting responses to nonphotic stimuli in Syrian hamsters.
Knoch ME; Gobes SM; Pavlovska I; Su C; Mistlberger RE; Glass JD
Eur J Neurosci; 2004 May; 19(10):2779-90. PubMed ID: 15147311
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of photic shifts with the 5-HT1A mixed agonist/antagonist NAN-190: intra-suprachiasmatic nucleus pathway.
Sterniczuk R; Stepkowski A; Jones M; Antle MC
Neuroscience; 2008 May; 153(3):571-80. PubMed ID: 18406538
[TBL] [Abstract][Full Text] [Related]
28. The selective tachykinin neurokinin 1 (NK1) receptor antagonist, GR 205,171, stereospecifically inhibits light-induced phase advances of hamster circadian activity rhythms.
Gannon RL; Millan MJ
Eur J Pharmacol; 2005 Dec; 527(1-3):86-93. PubMed ID: 16307740
[TBL] [Abstract][Full Text] [Related]
29. Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors.
Comer SD; McNutt RW; Chang KJ; De Costa BR; Mosberg HI; Woods JH
J Pharmacol Exp Ther; 1993 Nov; 267(2):866-74. PubMed ID: 8246161
[TBL] [Abstract][Full Text] [Related]
30. Characterization of mechanical withdrawal responses and effects of mu-, delta- and kappa-opioid agonists in normal and mu-opioid receptor knockout mice.
Fuchs PN; Roza C; Sora I; Uhl G; Raja SN
Brain Res; 1999 Mar; 821(2):480-6. PubMed ID: 10064835
[TBL] [Abstract][Full Text] [Related]
31. Distribution of delta opioid receptor immunoreactivity in the hamster suprachiasmatic nucleus and intergeniculate leaflet.
Byku M; Legutko R; Gannon RL
Brain Res; 2000 Feb; 857(1-2):1-7. PubMed ID: 10700547
[TBL] [Abstract][Full Text] [Related]
32. Role of nociceptin and opioid receptor like 1 on entrainment function in the rat suprachiasmatic nucleus.
Sugino T; Shimazoe T; Ikeda M; Watanabe S
Neuroscience; 2006; 137(2):537-44. PubMed ID: 16310969
[TBL] [Abstract][Full Text] [Related]
33. delta-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury.
Zhang J; Haddad GG; Xia Y
Brain Res; 2000 Dec; 885(2):143-53. PubMed ID: 11102568
[TBL] [Abstract][Full Text] [Related]
34. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
35. Immunomodulatory action of class mu-, delta- and kappa-opioid receptor agonists in mice.
Kowalski J
Neuropeptides; 1998 Aug; 32(4):301-6. PubMed ID: 10102674
[TBL] [Abstract][Full Text] [Related]
36. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
[TBL] [Abstract][Full Text] [Related]
37. Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: demonstration of an opioid kappa and delta inhibitory tone.
Ossipov MH; Kovelowski CJ; Wheeler-Aceto H; Cowan A; Hunter JC; Lai J; Malan TP; Porreca F
J Pharmacol Exp Ther; 1996 May; 277(2):784-8. PubMed ID: 8627559
[TBL] [Abstract][Full Text] [Related]
38. Induction of Fos-like immunoreactivity by opioids in guinea-pig brain.
Bot G; Chahl LA
Brain Res; 1996 Aug; 731(1-2):45-56. PubMed ID: 8883853
[TBL] [Abstract][Full Text] [Related]
39. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
[TBL] [Abstract][Full Text] [Related]
40. Effects of mu-, delta- and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice.
Mori T; Ito S; Kita T; Narita M; Suzuki T; Sawaguchi T
Eur J Pharmacol; 2006 Feb; 532(1-2):81-7. PubMed ID: 16464448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
